US Patent

US11633489 — Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant

Method of Use · Assigned to Pharmacosmos Holding AS · Expires 2036-06-22 · 10y remaining

Vulnerability score 70/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects a method for treating or preventing iron deficiency in a fetus or infant by administering an iron carbohydrate complex to the mother.

USPTO Abstract

Disclosed herein is a pharmaceutical composition comprising an iron carbohydrate complex for use in a method for treatment or prevention of an iron deficiency of a fetus or an infant, wherein the iron carbohydrate complex is administered to the mother of the fetus or infant.

Drugs covered by this patent

Monoferric (FERRIC DERISOMALTOSE) · Pharmacosmos

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3594`	—	Monoferric
`U-3594`	—	Monoferric
`U-3594`	—	Monoferric

Patent Metadata

Patent number: US11633489
Jurisdiction: US
Classification: Method of Use
Expires: 2036-06-22
Drug substance claim: No
Drug product claim: No
Assignee: Pharmacosmos Holding AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.